{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:28:45Z","timestamp":1786987725382,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research (MSFHR)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canadian Institutes of Health Research post-doctoral fellowship award"},{"name":"MSFHR scholar award"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ijdp.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.drugpo.2018.06.002","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T02:59:54Z","timestamp":1530154794000},"page":"1-2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Integrating hepatitis C and addiction care for people who inject drugs in the era of direct-acting antiviral therapy"],"prefix":"10.1016","volume":"59","author":[{"given":"Kathleen","family":"Bird","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Eugenia","family":"Soc\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2470-438X","authenticated-orcid":false,"given":"Lianping","family":"Ti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.drugpo.2018.06.002_bib0005","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1080\/10826084.2016.1271432","article-title":"Heroin and methamphetamine injection: An emerging drug use pattern","volume":"52","author":"Al-Tayyib","year":"2017","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.drugpo.2018.06.002_bib0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugpo.2017.07.002","article-title":"Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review","volume":"47","author":"Bajis","year":"2017","journal-title":"International Journal of Drug Policy"},{"issue":"11","key":"10.1016\/j.drugpo.2018.06.002_bib0015","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nrgastro.2017.106","article-title":"Direct-acting antiviral agents for HCV infection affecting people who inject drugs","volume":"14","author":"Grebely","year":"2017","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"2","key":"10.1016\/j.drugpo.2018.06.002_bib0020","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1017\/S1463423617000731","article-title":"Developing a community HCV service: Project ITTREAT (integrated community-based test \u2013 stage \u2013 TREAT) service for people who inject drugs","volume":"19","author":"Hashim","year":"2018","journal-title":"Primary Health Care Research & Development"},{"issue":"5","key":"10.1016\/j.drugpo.2018.06.002_bib0025","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7326\/M17-0118","article-title":"Expansion of treatment for hepatitis C virus infection by task shifting to community-based nonspecialist providers: A nonrandomized clinical trial","volume":"167","author":"Kattakuzhy","year":"2017","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.drugpo.2018.06.002_bib0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.drugpo.2017.05.042","article-title":"DOT-C: A cluster randomised feasibility trial evaluating directly observed anti-HCV therapy in a population receiving opioid substitute therapy from community pharmacy","volume":"47","author":"Radley","year":"2017","journal-title":"The International Journal on Drug Policy"},{"issue":"9","key":"10.1016\/j.drugpo.2018.06.002_bib0035","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/hiv.12501","article-title":"High prevalence of willingness to use direct-acting antiviral-based regimens for hepatitis C virus (HCV) infection among HIV\/HCV coinfected people who use drugs","volume":"18","author":"Soc\u00edas","year":"2017","journal-title":"HIV Medicine"},{"key":"10.1016\/j.drugpo.2018.06.002_bib0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugpo.2017.05.026","article-title":"HIV and hepatitis C treatment uptake among people who use drugs participating in the Amsterdam Cohort Studies, 1985-2015","volume":"47","author":"van Santen","year":"2017","journal-title":"The International Journal on Drug Policy"},{"issue":"11","key":"10.1016\/j.drugpo.2018.06.002_bib0045","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.drugpo.2015.05.007","article-title":"Human rights and access to hepatitis C treatment for people who inject drugs","volume":"26","author":"Wolfe","year":"2015","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2018.06.002_bib0050","unstructured":"World Health Organization. (2016, June). WHO | Global health sector strategy on viral hepatitis 2016-2021. Retrieved 17 May 2018, from: http:\/\/www.who.int\/hepatitis\/strategy2016-2021\/ghss-hep\/en\/."}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395918301646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395918301646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T12:57:40Z","timestamp":1538053060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395918301646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":10,"alternative-id":["S0955395918301646"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2018.06.002","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating hepatitis C and addiction care for people who inject drugs in the era of direct-acting antiviral therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2018.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}